Hub : Traits :

Crohns Disease (2012)

592 significantly associated models · 134 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 66697368 68152438 1 1 2.1e-11 1.1e-54 8.9e-47 15 MIER1
2 1 154325302 156671469 12 1 3.4e-09 3.6e-08 2.0e-01 94 ADAM15
3 2 27971195 29344127 1 1 3.3e-08 4.6e-06 6.8e-02 84 RP11-373D23.3
4 2 101981794 103767612 4 1 4.5e-10 1.5e-10 1.0e+00 100 IL1RL1
5 2 233227833 234904144 2 1 1.8e-37 3.9e-38 1.0e+00 100 ATG16L1
6 3 47911521 50921261 16 1 8.4e-15 1.1e-13 1.1e-01 95 AMT
7 5 39986432 41555158 2 2 2.3e-12 4.5e-34 5.8e-20 44 CARD6 PTGER4
8 5 95027958 97065386 4 1 1.1e-11 9.4e-12 1.0e+00 100 LNPEP
9 5 129797129 132900729 16 6 1.8e-19 1.4e-20 NaN NaN AC034220.3 P4HA2 RAD50 SLC22A4 SLC22A5
10 5 140789933 142230251 1 1 2.9e-08 6.1e-08 1.2e-01 92 NDFIP1
11 5 149124105 151236214 6 2 1.1e-16 1.6e-17 1.0e+00 100 ANXA6 ZNF300P1
12 9 4415824 5811733 1 1 2.2e-08 4.5e-11 1.1e-04 66 IGHEP2
13 9 116849447 118266112 1 1 7.6e-15 2.5e-15 7.2e-03 88 TNFSF15
14 9 138558883 140031290 5 1 5.0e-19 4.4e-20 1.0e+00 100 CARD9
15 10 34607015 36198981 3 1 1.7e-09 1.1e-09 1.0e+00 100 RP11-297A16.2
16 10 63870456 65264300 1 1 7.1e-13 3.4e-19 7.2e-11 47 ADO
17 12 39904158 41454590 1 1 2.7e-10 7.9e-18 5.0e-09 54 LRRK2
18 13 43756650 45157394 1 1 3.4e-08 7.3e-09 1.0e+00 100 LACC1
19 15 66662107 68183665 1 1 1.3e-07 1.1e-12 1.8e-06 55 SMAD3
20 16 27655848 29595483 23 1 2.4e-11 9.3e-10 8.4e-01 100 SULT1A2
21 16 49403920 51535063 7 6 1.7e-39 3.2e-61 3.1e-10 86 ADCY7 CYLD HEATR3 NKD1 NOD2
22 17 32561182 33976619 1 1 2.6e-07 9.5e-12 6.6e-11 8 CCT6B
23 17 37137299 39048774 6 1 7.4e-09 2.4e-09 4.5e-02 89 PNMT
24 17 39863901 41265776 1 1 2.6e-07 2.9e-08 2.3e-02 83 PTRF
25 19 9829303 11275258 1 1 2.5e-09 1.7e-08 5.8e-07 22 PDE4A
26 19 48505468 49906278 1 2 6.5e-08 4.3e-09 1.8e-01 95 FUT2
27 20 61522825 62912463 7 1 2.5e-11 7.3e-11 1.0e+00 100 ARFRP1
28 22 21075537 22685340 3 1 1.4e-09 1.2e-09 2.0e-01 96 CCDC116

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 34.99 37 37 112.1 -1.00 3.0e-40 AC034220.3 ADAM15 ADCY7 ADO AMT ANXA6 ARFRP1 ATG16L1 CARD6 CARD9 CCDC116 CYLD FUT2 HEATR3 IGHEP2 IL1RL1 LACC1 LNPEP LRRK2 MIER1 NDFIP1 NKD1 NOD2 P4HA2 PDE4A PNMT PTGER4 PTRF RAD50 RP11-297A16.2 RP11-373D23.3 SLC22A4 SLC22A5 SMAD3 SULT1A2 TNFSF15 ZNF300P1
Irritable Bowel Disease (IBD) 24.46 37 33 100.0 -0.98 5.4e-26 AC034220.3 ADAM15 ADCY7 ADO AMT ANXA6 ARFRP1 ATG16L1 CARD6 CARD9 CCDC116 CYLD FUT2 HEATR3 IGHEP2 IL1RL1 LACC1 LNPEP LRRK2 MIER1 NDFIP1 NKD1 NOD2 P4HA2 PDE4A PNMT PTGER4 PTRF RAD50 RP11-297A16.2 RP11-373D23.3 SLC22A4 SLC22A5 SMAD3 SULT1A2 TNFSF15 ZNF300P1
Ulcerative Colitis (UC) 8.29 13 7 21.2 -0.97 5.4e-08 ADO AMT ARFRP1 CARD6 CARD9 IGHEP2 PDE4A PNMT PTRF SMAD3 SULT1A2 TNFSF15 ZNF300P1
Verbal and Numeric Reasoning (VNR) 1.89 2 2 6.1 0.00 1.0e+00 AMT SULT1A2
Breast Cancer 1.76 4 1 3.0 -1.00 1.6e-04 ADAM15 P4HA2 SLC22A4 SLC22A5
Prostate Cancer 1.43 1 1 3.0 0.00 1.0e+00 ARFRP1
Body Mass Index (BMI) (2010) 1.37 1 1 3.0 0.00 1.0e+00 SULT1A2
Fasting Glucose 2.08 1 0 0.0 0.00 1.0e+00 RP11-373D23.3
HDL Cholesterol 1.86 2 2 6.1 0.00 1.0e+00 CCDC116 PNMT
LDL Cholesterol 1.55 1 0 0.0 0.00 1.0e+00 FUT2
Lupus 2.72 2 1 3.0 0.00 1.0e+00 CCDC116 FUT2
Primary Biliary Cirrhosis 2.20 1 1 3.0 0.00 1.0e+00 PNMT
Rheumatoid Arthritis 1.68 1 0 0.0 0.00 1.0e+00 PNMT
Schizophrenia 1.25 1 0 0.0 0.00 1.0e+00 LACC1
Triglycerides 2.79 1 1 3.0 0.00 1.0e+00 RP11-373D23.3
Ulcerative Colitis 7.49 9 4 12.1 0.99 1.3e-06 AMT ARFRP1 CARD9 IGHEP2 LRRK2 PNMT PTRF RP11-297A16.2 TNFSF15
Blood Eosinophil Count 17.54 14 12 36.4 -0.45 9.4e-02 AC034220.3 ADO CARD9 CCDC116 IGHEP2 LNPEP NDFIP1 P4HA2 RAD50 RP11-297A16.2 SLC22A4 SLC22A5 SMAD3 TNFSF15
Blood Platelet Count 4.03 16 13 39.4 -0.33 1.8e-01 AC034220.3 ADAM15 ADO ARFRP1 ATG16L1 FUT2 HEATR3 IGHEP2 NDFIP1 P4HA2 PNMT PTGER4 RAD50 RP11-373D23.3 SLC22A4 SLC22A5
Blood Red Count 1.04 8 5 15.2 -0.20 6.3e-01 AMT ARFRP1 IGHEP2 NDFIP1 PNMT PTGER4 RP11-373D23.3 SULT1A2
Blood White Count 7.42 16 14 42.4 -0.59 1.3e-02 AC034220.3 ADCY7 ADO ARFRP1 CARD9 CCDC116 HEATR3 LNPEP NDFIP1 P4HA2 PDE4A PNMT RAD50 RP11-373D23.3 SLC22A4 SLC22A5
Heel T-Score 0.67 2 2 6.1 0.00 1.0e+00 AMT CCDC116
BMI 1.54 4 2 6.1 -0.64 3.6e-01 AMT ARFRP1 PDE4A SULT1A2
Height 3.37 18 15 45.5 0.52 2.2e-02 AC034220.3 ADO ARFRP1 ATG16L1 CARD9 CCDC116 FUT2 IL1RL1 MIER1 NDFIP1 P4HA2 PDE4A PTRF RAD50 RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Waist Hip Ratio (WHR) 0.75 1 1 3.0 0.00 1.0e+00 FUT2
Systolic Blood Pressure 1.28 5 3 9.1 0.29 6.3e-01 ADO FUT2 LNPEP RP11-297A16.2 SMAD3
Smoking Status 1.36 2 0 0.0 0.00 1.0e+00 ADO ARFRP1
Allergy or Eczema 5.23 13 8 24.2 0.12 6.8e-01 ARFRP1 CCDC116 IGHEP2 IL1RL1 NDFIP1 P4HA2 PNMT PTGER4 RAD50 RP11-373D23.3 SLC22A5 SMAD3 SULT1A2
Cardiovascular Disease 2.67 6 3 9.1 0.35 3.9e-01 ADO ATG16L1 FUT2 RAD50 SLC22A4 SLC22A5
Hypothyroidism (self reported) 1.59 2 1 3.0 0.00 1.0e+00 FUT2 PTRF
Respiratory disease 10.05 10 8 24.2 -0.39 2.4e-01 AC034220.3 ARFRP1 LACC1 NDFIP1 P4HA2 PNMT RAD50 SLC22A4 SLC22A5 SMAD3
Lung FEV1/FVC ratio 2.78 8 5 15.2 0.65 5.8e-02 ADO FUT2 IL1RL1 P4HA2 PNMT SLC22A4 SLC22A5 SMAD3
Lung FVC 2.87 8 6 18.2 -0.86 2.7e-03 AC034220.3 ADCY7 ARFRP1 CARD9 P4HA2 PNMT SLC22A4 SLC22A5
Chronotype (morning person) 0.96 2 0 0.0 0.00 1.0e+00 CARD9 FUT2
Hair Pigment 0.26 2 2 6.1 0.00 1.0e+00 ADAM15 RP11-297A16.2
Tanning 0.24 2 1 3.0 0.00 1.0e+00 ADO IL1RL1
Hand grip strength (left) 2.97 4 4 12.1 -0.99 7.2e-04 AC034220.3 P4HA2 SLC22A4 SLC22A5
Number of treatments/medications taken 2.19 1 0 0.0 0.00 1.0e+00 SLC22A5
Average weekly spirits intake 1.46 2 0 0.0 0.00 1.0e+00 AMT FUT2
Relative age of first facial hair 1.26 1 0 0.0 0.00 1.0e+00 RP11-297A16.2
Systolic blood pressure, automated reading 1.21 1 1 3.0 0.00 1.0e+00 ADO
Impedance of leg (right) 0.97 2 1 3.0 0.00 1.0e+00 HEATR3 SULT1A2
Leg fat-free mass (left) 2.76 7 6 18.2 -0.97 5.1e-05 AC034220.3 ADO P4HA2 PDE4A SLC22A4 SLC22A5 SULT1A2
Trunk fat percentage 2.06 3 3 9.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Hand grip strength (right) 3.34 5 4 12.1 -0.81 5.2e-02 AC034220.3 P4HA2 SLC22A4 SLC22A5 SULT1A2
Current tobacco smoking 1.49 1 1 3.0 0.00 1.0e+00 ARFRP1
Fed-up feelings 1.53 1 0 0.0 0.00 1.0e+00 AMT
Heel bone mineral density (BMD) T-score, automated (left) 0.80 1 0 0.0 0.00 1.0e+00 AMT
High blood pressure 2.51 6 5 15.2 0.46 2.9e-01 AC034220.3 ADO FUT2 P4HA2 SLC22A4 SLC22A5
Hayfever, allergic rhinitis or eczema 5.56 13 7 21.2 0.05 8.7e-01 ARFRP1 CCDC116 IGHEP2 NDFIP1 P4HA2 PNMT PTGER4 RAD50 RP11-373D23.3 SLC22A4 SLC22A5 SMAD3 SULT1A2
Medication: Levothyroxine sodium 1.68 1 0 0.0 0.00 1.0e+00 PTRF
Sitting height 2.30 10 7 21.2 -0.59 5.8e-02 AC034220.3 ADO CARD9 CCDC116 FUT2 MIER1 P4HA2 SLC22A4 SLC22A5 ZNF300P1
Body mass index (BMI) 1.41 2 2 6.1 0.00 1.0e+00 AMT SULT1A2
Impedance of leg (left) 1.08 3 1 3.0 0.00 1.0e+00 CCDC116 HEATR3 SULT1A2
Leg predicted mass (left) 2.75 7 6 18.2 -0.97 5.3e-05 AC034220.3 ADO P4HA2 PDE4A SLC22A4 SLC22A5 SULT1A2
Trunk fat mass 2.11 3 3 9.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Waist circumference 1.65 3 2 6.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Alcohol usually taken with meals 0.96 1 0 0.0 0.00 1.0e+00 SULT1A2
Had other major operations 1.03 1 0 0.0 0.00 1.0e+00 ADO
Forced vital capacity (FVC) 1.10 1 1 3.0 0.00 1.0e+00 ARFRP1
Heel bone mineral density (BMD) T-score, automated (right) 0.77 1 0 0.0 0.00 1.0e+00 AMT
Qualifications: None of the above 1.08 2 1 3.0 0.00 1.0e+00 AMT SULT1A2
Mouth/teeth dental problems 1.36 1 0 0.0 0.00 1.0e+00 FUT2
Allergy 7.69 13 8 24.2 -0.16 5.8e-01 AC034220.3 ARFRP1 CCDC116 IGHEP2 NDFIP1 P4HA2 PNMT PTGER4 RAD50 RP11-373D23.3 SLC22A4 SLC22A5 SMAD3
Hayfever/allergic rhinitis (self-reported) 3.02 2 0 0.0 0.00 1.0e+00 PNMT SMAD3
Medication: Simvastatin 2.01 1 1 3.0 0.00 1.0e+00 FUT2
Fluid intelligence score 1.73 2 2 6.1 0.00 1.0e+00 AMT SULT1A2
Weight 2.29 7 5 15.2 -0.65 8.2e-02 AC034220.3 AMT ARFRP1 P4HA2 PDE4A SLC22A5 SULT1A2
Impedance of arm (right) 0.83 3 1 3.0 0.00 1.0e+00 NDFIP1 RP11-373D23.3 SMAD3
Arm fat percentage (right) 2.02 3 2 6.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Trunk fat-free mass 2.57 9 8 24.2 -0.84 2.5e-03 AC034220.3 ADO CARD9 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Hip circumference 1.80 4 2 6.1 0.60 4.0e-01 AMT ARFRP1 PDE4A SULT1A2
Alcohol intake versus 10 years previously 1.49 2 0 0.0 0.00 1.0e+00 AMT FUT2
Father's age at death 2.84 1 0 0.0 0.00 1.0e+00 SLC22A5
Hair/balding pattern: Pattern 3 1.40 1 0 0.0 0.00 1.0e+00 AC034220.3
Forced expiratory volume in 1-second (FEV1) 1.60 2 1 3.0 0.00 1.0e+00 ARFRP1 SLC22A5
Qualifications: A levels/AS levels or equivalent 1.49 2 1 3.0 0.00 1.0e+00 AMT SULT1A2
Mouth/teeth dental problems: Dentures 2.18 3 0 0.0 0.00 1.0e+00 FUT2 PNMT RAD50
Asthma 10.05 11 7 21.2 0.42 1.8e-01 AC034220.3 ARFRP1 LACC1 NDFIP1 P4HA2 PNMT RAD50 RP11-297A16.2 SLC22A4 SLC22A5 SMAD3
Medication: Cholesterol lowering 1.86 1 0 0.0 0.00 1.0e+00 FUT2
Forced expiratory volume in 1-second (FEV1), Best measure 1.60 3 1 3.0 0.00 1.0e+00 ADO ARFRP1 SLC22A5
Impedance of arm (left) 0.77 3 1 3.0 0.00 1.0e+00 ADCY7 RP11-373D23.3 SMAD3
Arm fat mass (right) 1.90 3 2 6.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Trunk predicted mass 2.57 9 8 24.2 -0.84 2.6e-03 AC034220.3 ADO CARD9 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Standing height 3.41 14 7 21.2 -0.70 3.7e-03 AC034220.3 ADO CARD9 CCDC116 FUT2 MIER1 P4HA2 PDE4A PTRF RAD50 RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Seen doctor (GP) for nerves, anxiety, tension or depression 1.11 1 0 0.0 0.00 1.0e+00 MIER1
Birth weight of first child 1.90 1 0 0.0 0.00 1.0e+00 SULT1A2
Peak expiratory flow (PEF) 1.67 1 1 3.0 0.00 1.0e+00 FUT2
Medication for cholesterol, blood pressure or diabetes 2.22 1 0 0.0 0.00 1.0e+00 FUT2
Gout (self-reported) 0.96 1 0 0.0 0.00 1.0e+00 RP11-373D23.3
Hypothyroidism/myxoedema (self-reported) 1.60 1 0 0.0 0.00 1.0e+00 PTRF
Medication: Ventolin 100micrograms inhaler 4.12 4 1 3.0 0.16 8.4e-01 ADO NDFIP1 PNMT SMAD3
Birth weight 1.99 1 0 0.0 0.00 1.0e+00 FUT2
Forced vital capacity (FVC), Best measure 1.01 1 1 3.0 0.00 1.0e+00 ARFRP1
Body fat percentage 2.01 3 3 9.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Leg fat percentage (right) 1.91 4 3 9.1 0.98 1.9e-02 AMT ARFRP1 LNPEP SULT1A2
Arm fat-free mass (right) 2.43 9 7 21.2 -0.71 2.2e-02 AC034220.3 CARD9 FUT2 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Comparative body size at age 10 1.50 2 1 3.0 0.00 1.0e+00 FUT2 SULT1A2
Wheeze or whistling in the chest in last year 3.06 4 3 9.1 -0.31 6.9e-01 ARFRP1 PNMT SLC22A5 SMAD3
Qualifications: College or University degree 2.12 3 2 6.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Medication: Allopurinol 0.95 1 0 0.0 0.00 1.0e+00 RP11-373D23.3
Medication: Seretide 50 evohaler 3.97 2 1 3.0 0.00 1.0e+00 P4HA2 SLC22A5
Whole body fat mass 2.05 4 3 9.1 0.66 3.4e-01 AMT ARFRP1 PDE4A SULT1A2
Leg fat mass (right) 1.73 3 3 9.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Arm predicted mass (right) 2.42 9 7 21.2 -0.71 2.3e-02 AC034220.3 CARD9 FUT2 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Pulse rate, automated reading 1.39 2 1 3.0 0.00 1.0e+00 AMT FUT2
Alcohol intake frequency. 2.28 2 1 3.0 0.00 1.0e+00 FUT2 SULT1A2
Comparative height size at age 10 3.28 7 7 21.2 -0.84 9.1e-03 AC034220.3 CARD9 FUT2 P4HA2 SLC22A4 SLC22A5 SULT1A2
Suffer from 'nerves' 1.35 1 1 3.0 0.00 1.0e+00 SULT1A2
Overall health rating 1.11 1 0 0.0 0.00 1.0e+00 AMT
Hypertension (Self-reported) 2.39 6 6 18.2 0.46 3.0e-01 AC034220.3 ADO FUT2 P4HA2 SLC22A4 SLC22A5
Illnesses of father: Heart disease 1.70 1 0 0.0 0.00 1.0e+00 SMAD3
Forced expiratory volume in 1-second (FEV1), predicted 2.45 5 3 9.1 -0.99 1.1e-04 AC034220.3 P4HA2 PDE4A SLC22A4 SLC22A5
Whole body fat-free mass 2.63 9 7 21.2 -0.84 2.2e-03 AC034220.3 ADO CARD9 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Leg fat-free mass (right) 2.66 7 6 18.2 -0.97 4.7e-05 AC034220.3 ADO P4HA2 PDE4A SLC22A4 SLC22A5 SULT1A2
Arm fat percentage (left) 1.98 3 2 6.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Handedness (chirality/laterality): Left-handed 1.39 1 0 0.0 0.00 1.0e+00 SULT1A2
Qualifications: nursing, teaching 1.08 1 0 0.0 0.00 1.0e+00 AMT
Mouth/teeth dental problems: Mouth ulcers 1.79 2 0 0.0 0.00 1.0e+00 PNMT TNFSF15
Medication for cholesterol 1.83 1 0 0.0 0.00 1.0e+00 FUT2
Asthma (self-reported) 10.01 11 8 24.2 0.42 1.7e-01 AC034220.3 ARFRP1 LACC1 NDFIP1 P4HA2 PNMT RAD50 RP11-297A16.2 SLC22A4 SLC22A5 SMAD3
Illnesses of father: None of the above (group 1) 1.47 1 0 0.0 0.00 1.0e+00 SMAD3
Smoking status: Current 1.39 1 0 0.0 0.00 1.0e+00 ARFRP1
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.51 2 1 3.0 0.00 1.0e+00 ARFRP1 PNMT
Whole body water mass 2.65 9 7 21.2 -0.84 2.2e-03 AC034220.3 ADO CARD9 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Leg predicted mass (right) 2.67 8 6 18.2 -0.87 2.6e-03 AC034220.3 ADO P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Arm fat mass (left) 1.84 4 2 6.1 0.65 3.5e-01 AMT ARFRP1 PDE4A SULT1A2
Number of self-reported non-cancer illnesses 2.88 3 0 0.0 -0.14 8.6e-01 ARFRP1 FUT2 SLC22A5
Medication: Blood pressure 2.62 4 2 6.1 0.99 6.3e-04 AC034220.3 P4HA2 SLC22A4 SLC22A5
High cholesterol (Self-reported) 2.33 1 1 3.0 0.00 1.0e+00 FUT2
Medication: Bendroflumethiazide 2.77 4 0 0.0 0.99 8.4e-03 AC034220.3 P4HA2 SLC22A4 SLC22A5
Medication: Paracetamol 1.44 1 0 0.0 0.00 1.0e+00 CYLD
Basal metabolic rate 2.60 9 6 18.2 -0.84 2.3e-03 AC034220.3 ADO CARD9 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Leg fat percentage (left) 2.04 3 3 9.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Arm fat-free mass (left) 2.46 8 7 21.2 -0.83 5.9e-03 AC034220.3 CARD9 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2
Irritability 0.94 1 0 0.0 0.00 1.0e+00 LNPEP
Diastolic blood pressure, automated reading 2.15 7 2 6.1 0.25 6.0e-01 AC034220.3 ADO AMT ARFRP1 LNPEP P4HA2 SLC22A5
Vascular/heart problems diagnosed by doctor 2.69 7 5 15.2 -0.53 1.8e-01 AC034220.3 ADO FUT2 P4HA2 SLC22A4 SLC22A5 SMAD3
Cholesterol lowering medication 1.74 1 0 0.0 0.00 1.0e+00 FUT2
Impedance of whole body 0.65 2 0 0.0 0.00 1.0e+00 HEATR3 RP11-373D23.3
Leg fat mass (left) 1.75 3 3 9.1 0.00 1.0e+00 AMT ARFRP1 SULT1A2
Arm predicted mass (left) 2.50 9 7 21.2 -0.73 1.7e-02 AC034220.3 CARD9 FUT2 P4HA2 PDE4A RP11-373D23.3 SLC22A4 SLC22A5 SULT1A2

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 15 0.451 1.64
GTEx Adipose Visceral Omentum 9 0.460 1.67
GTEx Adrenal Gland 7 0.499 1.73
GTEx Artery Aorta 11 0.386 1.67
GTEx Artery Coronary 8 0.709 1.79
GTEx Artery Tibial 22 0.612 1.71
GTEx Brain Caudate basal ganglia 7 0.795 1.79
GTEx Brain Cerebellar Hemisphere 8 0.557 1.80
GTEx Brain Cerebellum 8 0.419 1.77
GTEx Brain Cortex 8 0.800 1.91
GTEx Brain Frontal Cortex BA9 4 0.450 1.81
GTEx Brain Hippocampus 3 0.589 1.75
GTEx Brain Hypothalamus 4 0.707 1.90
GTEx Brain Nucleus accumbens basal ganglia 7 0.837 1.86
GTEx Brain Putamen basal ganglia 5 0.832 1.96
GTEx Breast Mammary Tissue 8 0.423 1.67
GTEx Breast Mammary Tissue (Male) 6 0.530 1.73
GTEx Breast Mammary Tissue (Female) 7 0.457 1.72
GTEx Cells EBV-transformed lymphocytes 4 0.292 1.64
GTEx Cells Transformed fibroblasts 19 0.472 1.67
GTEx Colon Sigmoid 6 0.426 1.70
GTEx Colon Transverse 10 0.507 1.76
GTEx Esophagus Gastroesophageal Junction 15 1.086 1.89
GTEx Esophagus Mucosa 24 0.755 1.90
GTEx Esophagus Muscularis 18 0.583 1.66
GTEx Heart Atrial Appendage 11 0.726 1.80
GTEx Heart Left Ventricle 6 0.410 1.82
GTEx Liver 2 0.292 1.71
GTEx Lung 20 0.730 1.81
GTEx Muscle Skeletal 13 0.470 1.65
GTEx Nerve Tibial 22 0.531 1.68
GTEx Ovary 7 0.795 1.85
GTEx Pancreas 4 0.254 1.68
GTEx Pituitary 6 0.558 1.77
GTEx Prostate 6 0.749 1.84
GTEx Skin Not Sun Exposed Suprapubic 17 0.717 1.80
GTEx Skin Sun Exposed Lower leg 20 0.575 1.73
GTEx Small Intestine Terminal Ileum 2 0.455 1.74
GTEx Spleen 8 0.589 1.84
GTEx Stomach 11 0.795 1.88
GTEx Testis 16 0.526 1.66
GTEx Thyroid 23 0.602 1.74
GTEx Uterus 2 0.368 1.72
GTEx Vagina 6 0.992 1.93
GTEx Whole Blood 17 0.896 1.93
METSIM Adipose 18 0.402 1.63
NTR Blood 18 0.762 1.90
ROSMAP Brain Pre-frontal Cortex 13 0.306 1.56
YFS Blood 21 0.465 1.68
CommonMind Brain Pre-frontal Cortex 21 0.401 1.58
TCGA Breast Tumor 3 0.401 1.66
TCGA Breast Normal 13 0.318 1.51
TCGA Ovarian Tumor 7 0.244 1.40
TCGA Prostate Tumor 16 0.478 1.63